ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
First Trust Mid Cap Growth AlphaDEX Fund

First Trust Mid Cap Growth AlphaDEX Fund (FNY)

81.56
1.31
(1.63%)
Closed January 05 4:00PM
81.67
0.11
(0.13%)
After Hours: 7:59PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
81.56
Bid
70.28
Ask
122.40
Volume
8,536
80.6675 Day's Range 81.67
65.04 52 Week Range 88.7386
Market Cap
Previous Close
80.25
Open
80.68
Last Trade
1
@
81.56
Last Trade Time
Financial Volume
$ 693,167
VWAP
81.2051
Average Volume (3m)
12,579
Shares Outstanding
4,550,000
Dividend Yield
-
PE Ratio
8.25
Earnings Per Share (EPS)
9.9
Revenue
2.33M
Net Profit
45.07M

About First Trust Mid Cap Growth AlphaDEX Fund

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Nasdaq AlphaDEX Mid Cap Growth Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the com... The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Nasdaq AlphaDEX Mid Cap Growth Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks that comprise the index. The index is designed to select growth stocks from the NASDAQ US 600 Mid Cap Index (the base index) that may generate positive alpha, or risk-adjusted returns, relative to traditional indices through the use of the AlphaDEX selection methodology. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Headquarters
Boston, Massachusetts, USA
Founded
-
First Trust Mid Cap Growth AlphaDEX Fund is listed in the Mgmt Invt Offices, Open-end sector of the NASDAQ with ticker FNY. The last closing price for First Trust Mid Cap Grow... was $80.25. Over the last year, First Trust Mid Cap Grow... shares have traded in a share price range of $ 65.04 to $ 88.7386.

First Trust Mid Cap Grow... currently has 4,550,000 shares outstanding. The market capitalization of First Trust Mid Cap Grow... is $365.14 million. First Trust Mid Cap Grow... has a price to earnings ratio (PE ratio) of 8.25.

FNY Latest News

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 138 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 129 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 127 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply to...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 124 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply to...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 118 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply to...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 136 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply to...

First Trust Cross-Lists Five Additional ETFs in Mexico

As Mexican demand for multi-factor and thematic ETFs grows, First Trust expands its offerings First Trust Advisors L.P. (“First Trust”), a global ETF provider and asset manager, announced today...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 129 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates apply to...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 128 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA. The following dates...

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 117 exchange-traded funds advised by FTA. The following dates apply to today's distribution declarations:...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.76940.95233851462980.790681.6779.451593980.39070659SP
4-6.04-6.8949771689587.687.7179.451305382.23415685SP
121.6252.0329017326679.93588.738679.11257983.21400001SP
268.1211.056644880273.4488.738669.561427879.13453631SP
5215.222.905364677566.3688.738665.041511675.33567822SP
1567.079.4912068734174.4988.738652.372052264.61559341SP
26034.0571.6691222947.5188.738630.13398160.07189305SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
$ 0.4621
(-28.80%)
7.08M
SMSTDefiance Daily Target 2x Short MSTR ETF
$ 5.69
(-26.30%)
24.62M
RAINRain Enhancement Technologies Holdco Inc
$ 5.59
(-23.42%)
155.16k
PTLEPTL Ltd
$ 9.35
(-23.30%)
967.95k
NXUNXU Inc
$ 0.725868
(-22.78%)
7.4M
NITON2OFF Inc
$ 2.6306
(145.85%)
350.92M
TGLTreasure Global Inc
$ 0.382
(101.58%)
330.82M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.59M
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
259.78M
NVDANVIDIA Corporation
$ 144.47
(4.45%)
222.72M

Discussion

View Full Feed
ElectricMountain53 ElectricMountain53 6 minutes ago
What Lebby said has got no value anymore. He also said deals were around the corner and many other things that haven´t come to fruition. Now he´s fired.
Let´s just wait what Yves has to say next week!!
You posting so much seems like pumping before the 9th!
Are you afraid of wh
LWLG
igotthemojo igotthemojo 28 minutes ago
i am speaking as the foremost authority on kblb that there is...bar none...i am saying that this stock is ready to fly...and will start flying BEFORE Feb...i have spoken...
KBLB
nowwhat2 nowwhat2 31 minutes ago
The Total 3

https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg



Sho nuff.......Whump......Much of this is XRP but I'll betcya Doge, etc. SOL, too

https://investorshub.advfn.com/uimage/uploads/2025/1/
XRPUSD
boi568 boi568 39 minutes ago
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 51 minutes ago
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 53 minutes ago
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 54 minutes ago
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 55 minutes ago
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 56 minutes ago
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 57 minutes ago
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 59 minutes ago
The Russes hit the jackpot?
BDEZ BDEZ 1 hour ago
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 1 hour ago
Not good, thanks for sharing.
sand sand 1 hour ago
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 1 hour ago
Moving hard soon 
EFSH
mining101 mining101 1 hour ago
Superb
MEGL
benz280c benz280c 1 hour ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 1 hour ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 1 hour ago
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 1 hour ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 2 hours ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 2 hours ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD

Your Recent History

Delayed Upgrade Clock